TrkAIII upregulated SOD2 expression, increased mitochondrial SOD2 activity and attenuated the accumulation of mitochondrial free radical ROS, thereby promoting NB cell line resistance to mitochondrial free radical ROS-mediated death and increasing tumor stem cell-like phenotype. The gene discussed is SOD2; the disease is neoplasm.